Jin R, Neufeld L, McGaha T
Nat Cancer. 2025; 6(2):239-252.
PMID: 39962208
DOI: 10.1038/s43018-025-00909-2.
Fleige L, Capellino S
Biol Sex Differ. 2025; 16(1):8.
PMID: 39901238
PMC: 11789415.
DOI: 10.1186/s13293-025-00689-5.
Pathak S, Le N, Oyama T, Odahara Y, Momotake A, Ikebukuro K
Biomolecules. 2025; 15(1).
PMID: 39858489
PMC: 11763011.
DOI: 10.3390/biom15010095.
Xu H, Wang Y, Liu G, Zhu Z, Shahbazi M, Reis R
Adv Sci (Weinh). 2024; 12(7):e2410011.
PMID: 39739630
PMC: 11831460.
DOI: 10.1002/advs.202410011.
Ji J, Chen L, Wu Z, Tang T, Zhu L, Zhu M
Sci Rep. 2024; 14(1):31424.
PMID: 39733119
PMC: 11682164.
DOI: 10.1038/s41598-024-83026-x.
Assembly and biological functions of metal-biomolecule network nanoparticles formed by metal-phosphonate coordination.
Xu W, Lin Z, Kim C, Wang Z, Wang T, Cortez-Jugo C
Sci Adv. 2024; 10(50):eads9542.
PMID: 39671490
PMC: 11641004.
DOI: 10.1126/sciadv.ads9542.
Simultaneous Stimulation of Peripheral Blood Mononuclear Cells with CpG ODN2006 and α-IgM Antibodies Leads to Strong Immune Responses in Monocytes Independent of B Cell Activation.
Fleige L, Capellino S
Cells. 2024; 13(22).
PMID: 39594572
PMC: 11593001.
DOI: 10.3390/cells13221822.
Synthetic polypeptides inhibit nucleic acid-induced inflammation in autoimmune diseases by disrupting multivalent TLR9 binding to LL37-DNA bundles.
Liu X, Chen S, Huang J, Du Y, Luo Z, Zhang Y
Nat Nanotechnol. 2024; 19(11):1745-1756.
PMID: 39160338
DOI: 10.1038/s41565-024-01759-2.
Immunotherapies Targeting Tumor-Associated Macrophages (TAMs) in Cancer.
Li M, Ye W, Luo K
Pharmaceutics. 2024; 16(7).
PMID: 39065562
PMC: 11280177.
DOI: 10.3390/pharmaceutics16070865.
Revolutionizing cancer therapy using tetrahedral DNA nanostructures as intelligent drug delivery systems.
Sharma A, Vaswani P, Bhatia D
Nanoscale Adv. 2024; 6(15):3714-3732.
PMID: 39050960
PMC: 11265600.
DOI: 10.1039/d4na00145a.
High amphipathicity of α-helical peptides enhances unmethylated CpG DNA-induced activation of mouse macrophage-like RAW264.7 cells.
Nishihara S, Nakamura N, Kawasaki K
Sci Rep. 2024; 14(1):16274.
PMID: 39009614
PMC: 11251158.
DOI: 10.1038/s41598-024-67166-8.
Synergistic Effects of Metal-Organic Nanoplatform and Guanine Quadruplex-Based CpG Oligodeoxynucleotides in Therapeutic Cancer Vaccines with Different Tumor Antigens.
Li X, Ebara M, Shirahata N, Yamazaki T, Hanagata N
Vaccines (Basel). 2024; 12(6).
PMID: 38932378
PMC: 11209203.
DOI: 10.3390/vaccines12060649.
Recognition of by Toll-like receptor 9 is altered during persistence.
Diallo A, Overman G, Sah P, Liechti G
Infect Immun. 2024; 92(7):e0006324.
PMID: 38899879
PMC: 11238561.
DOI: 10.1128/iai.00063-24.
Critical role of the gut microbiota in immune responses and cancer immunotherapy.
Li Z, Xiong W, Liang Z, Wang J, Zeng Z, Kolat D
J Hematol Oncol. 2024; 17(1):33.
PMID: 38745196
PMC: 11094969.
DOI: 10.1186/s13045-024-01541-w.
Surface charge-dependent cytokine production using near-infrared emitting silicon quantum dots.
Chinnathambi S, Shirahata N, Lesani P, Thangavel V, Pandian G
Sci Rep. 2024; 14(1):9618.
PMID: 38671084
PMC: 11053057.
DOI: 10.1038/s41598-024-60536-2.
Programming peptide-oligonucleotide nano-assembly for engineering of neoantigen vaccine with potent immunogenicity.
Xiang Z, Lu J, Rao S, Fu C, Yao Y, Yi Y
Theranostics. 2024; 14(6):2290-2303.
PMID: 38646651
PMC: 11024849.
DOI: 10.7150/thno.93395.
Immunostimulation of Asian elephant () blood cells by parapoxvirus ovis and CpG motif-containing bacterial plasmid DNA upregulates innate immune gene expression.
Haycock J, Maehr T, Dastjerdi A, Steinbach F
Front Immunol. 2024; 15:1329820.
PMID: 38590526
PMC: 10999609.
DOI: 10.3389/fimmu.2024.1329820.
Vaccination with a combination of STING agonist-loaded lipid nanoparticles and CpG-ODNs protects against lung metastasis via the induction of CD11bCD27 memory-like NK cells.
Khalifa A, Nakamura T, Sato Y, Harashima H
Exp Hematol Oncol. 2024; 13(1):36.
PMID: 38553761
PMC: 10981311.
DOI: 10.1186/s40164-024-00502-w.
Evaluation of different types of adjuvants in a malaria transmission-blocking vaccine.
Yu X, Min H, Yao S, Yao G, Zhang D, Zhang B
Int Immunopharmacol. 2024; 131:111817.
PMID: 38460299
PMC: 11090627.
DOI: 10.1016/j.intimp.2024.111817.
Introducing adjuvant-loaded particulate hepatitis B core antigen as an alternative therapeutic hepatitis B vaccine component.
Su J, Harati Taji Z, Kosinska A, Ates Oz E, Xie Z, Bielytskyi P
JHEP Rep. 2024; 6(4):100997.
PMID: 38425450
PMC: 10904195.
DOI: 10.1016/j.jhepr.2023.100997.
